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Materials: All chemicals were purchased from Sigma-Aldrich, Inc. (St. Louis, MO). Ester substrates and 
product standards were synthesized in a standard esterfication reaction and purified by distillation. 
NADPH was obtained from BioCatalytics, Inc. (Pasadena, CA). Buspirone and racemic 
6-hydroxybuspirone were provided by Bristol-Myers Squibb (BMS).  
 
Protein expression and purification: Protein was expressed and purified as described (Peters et al. J. 
Am. Chem. Soc. 2003, 125, 13442-50). 
 
Bioconversions: 900 µl bioconversions for determining regioselectivity and ee contained 50 or 500 nM 
protein, 5 mM substrate and 500 µM NADPH co-factor in 1% DMSO, 1% acetone in 100 mM Epps 
buffer, pH 8.2. Reaction time was 3 hours at RT. The reaction was acidified with 90 µl 7% perchloric 
acid to quench the reaction by precipitating protein. 1-Heptanol was added as internal standard. After 
centrifugation for 10 min at 13,000 x g, the product was extracted from the supernatant with 
dichloromethane and analyzed by GC. All reactions were set up at least in triplicate. 
NADPH consumption rates were monitored under the same conditions as above but at lower substrate 
concentration (250 µM) at 340 nm using a Cary 100 BioSpectrophotometer. Rates were corrected for 
background NADPH consumption measured without substrate. All rates were measured in triplicate. 
 Bioconversions for measuring product formation followed the same conditions as described 
above and were quenched after one or two minutes by adding perchloric acid. To enhance TTN, 
bioconversions used an isocitrate regeneration system instead of supplying NADPH directly. Final 
concentrations for these reactions were: 1 U/ml isocitrate dehydrogenase, 0.05 mM NADP+ and 25 mM 
isocitrate. 15 ml reactions were carried out with the concentrations described in the manuscript, stirred 
and supplied with air by bubbling directly into the reaction with a flow rate of about 2.5 ml/min. In 
addition to the standard buffer, 0.5% DMF was present in these reactions which seemed beneficial for 
enzyme stability. 
 
GC Analysis: Identification and quantification of analytes were performed using product standards and 
3-point calibration curves with internal standard. Sample injection volume was 1 µl. Analysis was 
performed in triplicate on a Hewlett-Packard 5890 Series II Plus gas chromatograph with a flame-
ionization detector (FID). Direct analysis of the extract was performed on a chiral CycloSil-B column 
(Agilent Technologies). The temperature program for separating the components is as follows: 250°C 
inlet, 300°C detector, 100°C oven for 1 min, then 10°C/min gradient to 170°C, holding for 10 min, then 
10°C/min to 250, holding for 3 min. 
 
Retention times (in minutes) of substrates and products described in publication. 
Substrate Retention Time Product Retention Time (S) Retention Time (R) 
 1a (Me) 6.82 2a (Me) 9.23 9.28 
1b (Et) 7.48 2b (Et) 9.74 9.83 
1c (Pr) 8.60 2c (Pr) 11.32 11.41 
1d (Bu) 10.03 2d (Bu) 13.67 13.74 
3b (Et) 10.20 m-chloro ethyl mandelate  13.95 14.35 
3c (Pr) 12.05 m-chloro propyl mandelate 17.04 17.48 
3d (Bu) 14.79 m-chloro butyl mandelate 20.34 20.53 
 
 
Buspirone Bioconversions: 0.5 ml bioconversion for determining regioselectivity and ee were set up 
with 50 or 500 nM protein, 2 mM buspirone, and 500 µM NADPH co-factor in 1% DMSO, 1% acetone 
and 100 mM Epps buffer, pH 8.2. Reaction time was 3 hours at RT.  The sample was extracted by 
adding 0.5 THF, 50 µl 8.5% phosphoric acid, 166 µl saturated sodium chloride solution, and 125 µl 
MTBE. 400 µl of the organic layer was removed after centrifugation at 20,800 x g for 3 minutes and 
combined with 0.5 ml of a second extraction (0.5 ml THF and 125 µl MTBE). The organic phase was 
concentrated by evaporation to about 30 µl. 10 µl DMSO, 10 µl acetone, and 480 µl 0.1 M Epps, pH 
8.2 were added to the concentrated sample. A 15 ml bioconversion using the regeneration system 
described above was used to generate the material for NMR analysis. 
 
HPLC Analysis: Analysis of the products was carried out on a Waters 2690 Separation Module with a 
Waters 996 Photodiode Array Detector using a chiral Chiralpak AD column (250 x 4.6 mm, 20 µm 
particle size). The mobile phase was 85% ethanol/15% acetonitrile/0.06% triethylamine with a flow rate 
of 1 ml/min.  A 20 °C column temperature and a 20 µl injection volume were used.  The detection was 
at 243 nm. The retention times are as follows: buspirone: 12.8 min., (R)-6-hydroxybuspirone: 8.1 min., 
(S)-6-hydroxybuspirone: 13.6 min. 
 
NMR: The 15 ml bioconversion was extracted with 15 ml chloroform twice. The organic layer was 
concentrated under reduced pressure using a rotary evaporator. Thin-layer chromatography (TLC) was 
carried out on in 4:1 chloroform:hexane with 0.1% THF. The product band was removed and eluted 
from the silica in chloroform. The samples were dried and suspended in DMSO-d6. 1H NMR spectra 
were recorded on a Mercury 300 Spectrometer (300 MHz) and are internally referenced to residual 
protic solvent signals (DMSO = 2.50 ppm). 1H NMR (DMSO-d6, ppm) δ 1.406 – 1.584 (m, 12H), 2.275 
– 2.275 (m, 6H), 2.645 - 2.657 (m, 2H), 3.603 (t, J=6.3 Hz, 2H), 3.693 (t, J=4.8 Hz, 4H), 4.108 (d, J 
=4.5 Hz, 1H), 5.917 (d, J=4.5 Hz, 1H), 6.612 (t, J=4.5 Hz, 1H), 8.338 (d, J=4.8 Hz, 2H) 
 
Reference: Full author list for reference 17(d): DeSantis, G.; Zhu, Z.; Greenberg, W. A.; Wong, K.; 
Chaplin, J.; Hanson, S. R.; Farwell, B.; Nicholson, L. W.; Rand, C. L.; Weiner, D. P.; Robertson, D. E.; 
Burk, M. J., J. Am. Chem. Soc. 2002, 124, 9024-5. 
  
 1H NMR spectrum of 6-hydroxybuspirone standard 
 
  1H NMR spectrum of TLC separated product of bioconversion of buspirone 
 
 
 
 
 
 
 
